| HOME >> BIOLOGY >> TECHNOLOGY |
Marketing, selling and
general and administrative 11,696 10,771 44,801 40,627
Research and development 1,965 1,321 5,658 4,828
13,661 12,092 50,459 45,455
Operating income 746 17 3,263 2,347
Interest expense, net (129) (176) (588) (914)
Other 185 57 (1) 416
Income (loss) before income
taxes 802 (102) 2,674 1,849
Income tax provision (benefit) (4) (163) 57 (58)
Net Income $ 806 $ 61 $ 2,617 $ 1,907
Earnings per share:
Basic $ .05 $ - $ .15 $ .11
Diluted $ .04 $ - $ .15 $ .11
Shares used in computing
earnings per share:
Basic 17,666,940 17,347,880 17,538,254 17,298,352
Diluted 18,093,058 17,542,228 17,926,384 17,399,719
CONSOLIDATED SEGMENT REVENUE DETAIL
(dollars in thousands)
Three Months Year Ended
Ended December 31, December 31,
2007 2006 2007 2006
DBM $ 17,107 $ 14,792 $ 65,794 $ 57,493
Hybrid/Synthetic 591 332 1,760 1,270
Core Revenue 17,698 15,124 67,554 58,763
Traditional Tissue 4,491 4,674 17,623 16,955
Spinal Allografts 2,438 3,027 10,739 13,795
Client Services 2,085
'/>"/>
| SOURCE Osteotech, Inc. Copyright©2008 PR Newswire. All rights reserved |